Africa has seen a 306% increase in the number of central nervous system trials taking place over the past decade, the largest increase for any region worldwide.
The region now ranks in first for the total number of trials taking place, compared to its sixth placed ranking in 2010.
These figures come from GlobalData’s extensive clinical trials database which seeks to track the number of clinical trials taking place in countries around the world, in numerous therapy areas.
Africa
Africa saw the biggest increase in central nervous system related trials.
Between 2010 and 2020, there was a 306% increase in the number of trials taking place.
In 2020, the largest proportion of trials in the region took place in Egypt with 87.7% of all trials in the region taking place there.
Tunisia and South Africa had the next largest percentage of trials taking place in the region with 4.6% and 3.1%, respectively.
Asia-Pacific
The Asia-Pacific region saw a 107% increase in the number of central nervous system trials taking place.
China saw the largest amount of trials taking place, in 2020, at 46.7%.
Trials in India and Australia also made up a large proportion of the trials taking place with 20.5% and 8.1%, respectively.
Middle East
The Middle East saw a 34% increase in the number trials taking place.
Iran, Israel and Saudi Arabia made up the most trials in the region, with 82.4%, 10.7% and 2.9%, respectively.
Europe
Europe saw a 14% decrease in central nervous system related trials taking place.
Russia saw the largest percentage of trials taking place in the region at 7.7%.
Spain and Germany also made up a significant proportion of the trials taking place.
North America
North America saw a decrease in the number of central nervous system trials.
The region saw a 15% decrease in the number of trials.
The United States made up 85.2% the largest proportion of trials taking place in the region.
Canada and Mexico also made up a large amount of the trials taking place with 12.5% and 2.4%, respectively.
South and Central America
South and Central America saw the biggest decrease in central nervous system trials.
The number of trials in the region fell by 36% between 2010 and 2020.
Brazil saw the largest percentage of trials taking place in the region with 46.5%.
